LogicBio Therapeutics Competitors and Similar CompaniesClear all
Immunocore's competitors and similar companies include Agenus, Lexicon Pharmaceuticals and Intellia Therapeutics.
 Immunocore Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases. |  Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. |  Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. |  Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry. | |
Founding Date | Founding Date 2008 | Founding Date 1994 | Founding Date 1995 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Milton, GB HQ Conshohocken, US Rockville, US | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more | Locations Cambridge, US HQ |
Employees | Employees 493 | Employees 8174% decrease | Employees 20216% increase | Employees 40323% decrease |
Valuation ($) | Valuation ($) 1.6 b | Valuation ($) 96.2 m | Valuation ($) 737.4 m | Valuation ($) 1.7 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $400m (FY, 2025) | Revenue (est.) $114.2m (FY, 2025) | Revenue (est.) $49.8m (FY, 2025) | Revenue (est.) $67.7m (FY, 2025) |
Cost of goods | Cost of goods $5.1m (FY, 2025) | Cost of goods $1m (FY, 2025) | Cost of goods $274k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $414.7m (FY, 2025) | Gross profit $113.2m (FY, 2025) | Gross profit $49.5m (FY, 2025) | Gross profit N/A |
Net income | Net income ($35.5m) (FY, 2025) | Net income ($3.1m) (FY, 2025) | Net income ($50.3m) (FY, 2025) | Net income ($412.7m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 565m | Total funding raised $ 171.1m | Total funding raised $ 244.7m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Agenus
HQ
Lexington, US
Employees
81
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View companyLexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
View companyIntellia Therapeutics
HQ
Cambridge, US
Employees
403↓ 23% decrease
Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.
View company